✦ LIBER ✦

O85 SHOULD WE AWAIT INTERFERON-FREE REGIMENS TO TREAT HCV GENOTYPE 1 TREATMENT-NAIVE PATIENTS? A COST-EFFECTIVENESS ANALYSIS (ANRS 12188)

✍ Scribed by Deuffic-Burban, S.; Schwarzinger, M.; Obach, D.; Mallet, V.; Pol, S.; Pageaux, G.-P.; Canva, V.; Deltenre, P.; Roudot-Thoraval, F.; Larrey, D.; Dhumeaux, D.; Mathurin, P.; Yazdanpanah, Y.

Book ID: 122156200
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 58 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)60087-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Should we await IFN-free regimens to tre

Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141)

✍ Deuffic-Burban, Sylvie; Schwarzinger, Michaël; Obach, Dorothée; Mallet, Vincent; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 704 KB

809 IMMEDIATE OR DELAYED TREATMENT INITI

809 IMMEDIATE OR DELAYED TREATMENT INITIATION WITH “PREVIR” CONTAINING REGIMENS IN HCV-INFECTED NAIVE GENOTYPE 1 (G1) PATIENTS WITHOUT SEVERE FIBROSIS? A COST-EFFECTIVENESS ANALYSIS (ANRS N°12188)

✍ Deuffic-Burban, S.; Schwarzinger, M.; Mallet, V.; Pol, S.; Pageaux, G.-P.; Canva 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 133 KB